{"schema_version":"secwatch.filing_event.v1","accession":"0001834376-24-000021","form_type":"8-K","ticker":"INNV","cik":"0001834376","company_name":"InnovAge Holding Corp.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.575692+00:00","generated_at":"2026-06-02T19:56:22.718188+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"InnovAge reports Q3 fiscal 2024 revenue up 12% YoY to $193.1M; net loss narrows to $0.04 EPS","bullets":["Total revenue $193.1M, up 11.9% YoY from $172.5M; participant census 6,820 vs 6,310 (+8%).","Net loss $6.2M vs $7.3M YoY; loss per share ($0.04) vs ($0.05), improvement of $0.01.","Center-level contribution margin $34.0M, up 18.1% YoY; margin rate 17.6% vs 16.7%.","Adjusted EBITDA $3.6M vs $3.8M YoY; margin 1.9% vs 2.2%, slight decrease.","Cash & short-term investments $99.3M, debt $81.3M; ended Q3 with $54.1M cash + $45.2M ST investments."],"urls":{"canonical":"https://secwatch.observer/filing/0001834376-24-000021","json":"https://secwatch.observer/filing/0001834376-24-000021.json","markdown":"https://secwatch.observer/filing/0001834376-24-000021.md","text":"https://secwatch.observer/filing/0001834376-24-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834376/000183437624000021/0001834376-24-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834376/000183437624000021/innv-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T19:56:22.718188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"21c2db3cb91080f42f31c50606ac57298ab7f7cb","claim":"InnovAge Holding Corp. reported fiscal third quarter ended March 31, 2024 results: revenue $ 193,071, net income $(6,184), EPS $ (0.04).","evidence_excerpt":"care.” Financial Results Three Months Ended March 31, Nine Months Ended March 31, 2024 2023 2024 2023 in thousands, except percentages and per share amounts Total revenues $ 193,071 $ 172,539 $ 564,454 $ 511,213 Loss Before Income Taxes (6,408) (8,675) (20,873) (39,304) Net Loss (6,184) (7,310) (20,967) (31,557) Net Loss margin (3.2) % (4.2) % (3.7) % (6.2) %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1834376/000183437624000021/0001834376-24-000021-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal third quarter ended March 31, 2024"},{"label":"Revenue","value":"$ 193,071"},{"label":"Net income","value":"$(6,184)"},{"label":"EPS","value":"$ (0.04)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}